Which induction therapy for potentially resectable cases?

Date 07 October 2016
Event ESMO 2016 Congress
Session Optimal treatment of stage III NSCLC
Topics Anticancer agents
Surgical Oncology
Non-Small Cell Lung Cancer
Therapy
Biological Therapy
Radiation Oncology
Presenter Wilfried Eberhardt
Authors W.E. Eberhardt
  • Dept. Medical Oncology, University Hospital Essen Westdeutsches Tumorzentrum, 45122 - Essen/DE